FDA Approves Abaloparatide to Treat Men with Osteoporosis & a High Risk of Fracture
First Biosimilar to Adalimumab (Humira) Enters the U.S. Market After Years of Legal Battles
FDA Officials Speak Out: New Approvals & Safety Concerns Discussed
Mitigating Drug Shortages: FDA Officials Say Communication Is Crucial
Patients on Dialysis Taking Denosumab May Be at Risk of Severe Hypocalcemia
Belimumab Promising for Children with Lupus Nephritis
FDA Approves Riabni, a Rituxumab Biosimilar, to Treat Patients with RA
FDA Approves Secukinumab for Children with Enthesitis-Related Arthritis & PsA
FDA Authorizes New Long-Acting, Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals
- 1
- 2
- 3
- …
- 27
- Next Page »